Next-Generation Vaccines Leveraging T Cell-Centric Design, Mucosal Immunity, and Trained Innate Immunity for Respiratory and Enteric Pathogens
Vaccines · 21.05.2026 · 14 (5) · 462
DOI: 10.3390/vaccines14050462 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 21.05.2026. Verfasst von Md Abdus Salam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biotechnology & Biomedical Engineering, Rajshahi Medical University, Rajshahi 6100, Bangladesh. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Next-generation vaccines are being developed to elicit durable and cross-protective immune responses against diverse pathogens, particularly those targeting the respiratory and enteric systems. By strategically engaging T cell-centric antigen design, mucosal immune engagement, and induction of trained innate immunity, these innovative platforms are expected to reshape the paradigm of immunoprophylaxis and to offer promising avenues for enhanced protection against complex infectious diseases. Conventional antibody-based vaccines, though effective against many infections, often lack the capacity to induce durable or cross-protective immunity at mucosal surfaces. Advances in antigen design, delivery platforms, and adjuvant technologies now facilitate precise activation of tissue-resident memory T cells and enhancement of mucosal secretory IgA responses, thereby achieving sterilizing immunity at barrier surfaces while reinforcing systemic immune protection. Advanced delivery platforms, including lipid nanoparticles, viral vectors, and nano or liposomal carriers, further refine antigen presentation, enhancing stability, targeting, and overall immunogenicity. Concurrently, progress in understanding trained innate immunity highlights opportunities to induce broad, non-antigen-specific protection through epigenetic and metabolic reprogramming of innate cells. The integration of these adaptive and innate mechanisms may enhance early pathogen control, limits transmission, and strengthens defense against variant and antimicrobial-resistant pathogens across diverse populations. However, translating these immunological insights into safe, scalable, and globally accessible vaccines remains a major challenge. This review explores the emerging conceptual framework of next-generation vaccines that demonstrate partial integration of these axes in preclinical models, though human translation and functional synergy require Phase II validation. It highlights progress toward next-generation vaccines leveraging integrated adaptive and innate immune reprogramming for superior protection against respiratory and enteric pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Biotechnology & Biomedical Engineering, Rajshahi Medical University, Rajshahi 6100, Bangladesh.
- Department of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, IN 47907, USA.
- Purdue University Interdisciplinary Life Sciences Graduate Program, Purdue University, West Lafayette, IN 47907, USA.
- Department of Pharmacy Practice, Purdue University College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA.
- Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
- Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, IN 47907, USA.
ORCID-Profile: Md Abdus Salam, Md Yusuf Al-Amin, Kasireddy Sudarshan
Zitieren
APA
Salam, M. A., Al-Amin, M. Y., Sudarshan, K., Lynch, A., Reyes, V., & Stevenson, M. (2026). Next-Generation Vaccines Leveraging T Cell-Centric Design, Mucosal Immunity, and Trained Innate Immunity for Respiratory and Enteric Pathogens. Vaccines, 14(5), 462. https://doi.org/10.3390/vaccines14050462
Vancouver
Salam MA, Al-Amin MY, Sudarshan K, Lynch A, Reyes V, Stevenson M. Next-Generation Vaccines Leveraging T Cell-Centric Design, Mucosal Immunity, and Trained Innate Immunity for Respiratory and Enteric Pathogens. Vaccines. 2026;14(5):462. doi:10.3390/vaccines14050462
BibTeX
@article{Salam2026,
author = {Salam, Md Abdus and Al-Amin, Md Yusuf and Sudarshan, Kasireddy and Lynch, Aidan and Reyes, Victor and Stevenson, Madeline},
title = {Next-Generation Vaccines Leveraging T Cell-Centric Design, Mucosal Immunity, and Trained Innate Immunity for Respiratory and Enteric Pathogens},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {5},
pages = {462},
doi = {10.3390/vaccines14050462}
}
EUVIMED